2023
DOI: 10.1016/j.semarthrit.2022.152159
|View full text |Cite
|
Sign up to set email alerts
|

Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 45 publications
0
1
0
Order By: Relevance
“…Here, we instead investigated the contribution of S-Fib in driving neutrophil activation. Data on S-Fib from arthritis patients show that they are heterogenous and potent cytokine producers with altered surface marker expression and may thus influence neutrophil function in several ways ( 8 , 20 ). Indeed, studies in RA show a clear interaction between S-Fib and neutrophils.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Here, we instead investigated the contribution of S-Fib in driving neutrophil activation. Data on S-Fib from arthritis patients show that they are heterogenous and potent cytokine producers with altered surface marker expression and may thus influence neutrophil function in several ways ( 8 , 20 ). Indeed, studies in RA show a clear interaction between S-Fib and neutrophils.…”
Section: Discussionmentioning
confidence: 99%
“…Synovial fibroblasts (S-Fib) are gaining increasing attention as drivers of inflammation in arthritic diseases [such as rheumatoid arthritis (RA)], e.g., as activators of immune cells ( 8 ). For example, S-Fib drive metabolic alterations in macrophages, resulting in increased viability, whilst macrophages promote fibroblast invasiveness ( 9 , 10 ).…”
Section: Introductionmentioning
confidence: 99%
“…In addition to their ability to destroy joint tissue directly, synovial fibroblasts can also act as APCs and eventually stimulate pathogenic T lymphocytes [ 56 ]. It has been shown that SF can activate MHCII-restricted T cell hybridomas specific for arthritogenic peptides [ 57 ].…”
Section: Introductionmentioning
confidence: 99%